Replies to post #35617 on Ayala Pharmaceuticals Inc (ADXS)

[tinfoillurker]

We're never told anything of importance or given any answers to legitimate questions. I'm in agreement with you. There were 50,000 things he could have and should have spoken about today and none of them were given any attention.

As usual, I'll take the cynical stance opposite many who are posting. The lack of attention to financial direction tells me they're sitting on a hope and a prayer just like we are. At an "investor conference", the #1 question is going to be "is this worth investing in". By not giving any attention to that, they convey that they don't have an answer and so don't want to call attention to that question.

This was the worst outcome from the presentation if you ask me. Positive news would've been welcome. Negative news would've been hated but also welcome because at least it would clear things up and let us move forward. Instead, we get nothing. Might as well not even have presented, there was nothing discussed that isn't available on the website.

Seriously depressing.

[Gantor50]

Meish, I certainly am not anti-DOC the way some are, but I don't understand your comments about his departure and the impact on the PPS? The stock actually went up going into Investor Day and crashed immediately after. There is no evidence I can find in the stock chart that suggests major leaks of DOCs leaving triggered the sell-off? In fact shorts covered almost 2M shares leading up to Investor Day.

It appears that DOCs lack of delivering a deal is what triggered the crash. And it feels like a major Tute demanded his replacement. JMO.

[ignatiusrielly35]

"Ig, I'm sure he's working to raise money through partnering deals, but that's not "news" of any meaningful kind IMHO -- that's what biotech CEO's are ALWAYS doing -- it's their core job."

But that is my point, Meisha. The company has clearly decided to change course, going from a "preserve rights and dilute" plan to a "sell or license rights" approach. This is most likely the reason DOC was ousted, due to his preference for the latter option, which became untenable due to the share price suppression. So when you say that everyone assumes CEOs are always looking to make deals so why bother mentioning it(?), in this case it actively confirms that ADXS is changing course and that they are working on accretive deals. And I am fairly certain that this issue--in what manner will they raise capital--is of primary concern to both the legitimate "market" and the short manipulators.